Impact of Therapeutic Alliance on Dropout in a Naturalistic Sample of Patients With Borderline Pathology Receiving Residential DBT

Completed

• Conditions: Borderline Personality Disorder; Psychotherapy; Dropout

• Registration Number: NCT05289583
• Lead Sponsor: Evangelisches Krankenhaus Bielefeld gGmbH

Brief Summary

Participants with Borderline pathology (≥ 3 DSM-IV-criteria) receiving an inpatient Dialectical Behavior Therapy (DBT) program completed a quality assurance questionnaire set assessing demographic information and pretreatment psychopathology during the days of their inpatient stay. Beyond that, changes of therapists were documented.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-01-01
• Primary Completion: 2021-12-31
• Study Completion: 2022-02-28
• Status Verified: 2022-03
• Study First Submitted: 2022-03-11
• Study First Submitted QC: 2022-03-11
• Study First Posted: 2022-03-21
• Last Update Submitted: 2022-03-21
• Last Update Posted: 2022-04-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

• three or more criteria for BPD as defined by DSM-5 (Borderline Personality characteristics; BPC)

Exclusion Criteria

• inability to contract and consent,
• other severe mental disorders (bipolar disorder, acute psychosis),
• current alcohol,
• illicit or not prescribed drug use,
• simultaneous participation in other treatment studies,
• pregnancy or breastfeeding,
• an inability to negotiate a non-suicide agreement,
• ongoing traumatic contact with the perpetrator, and
• a Body Mass Index < 16.5.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rate of Dropout	8-10 weeks	premature termination of treatment

Trial Locations

Locations (1)

Research Department; 🇩🇪 Bielefeld, Germany